Loading
CRISPR and Genetic Engineering · Journal article
Current Advances in Medicine. · July 29, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review synthesizing current understanding of antimicrobial resistance mechanisms and discussing emerging therapeutic approaches including CRISPR-Cas systems, AI-driven diagnostics, combination therapies, and vaccination strategies. The source identifies promising directions but does not present primary evidence, clinical outcomes, or quantitative efficacy data to support any specific intervention.
Narrative review. Global populations affected by antimicrobial resistance; discussion spans human healthcare, animal husbandry, and agriculture.
AMR has acquired novel mechanisms such as enzyme alteration and biofilm development that render standard antibiotics less effective Promising strategies include novel drug delivery platforms, synergistic drug combinations, and CRISPR-Cas gene-editing technologies AI-based diagnostics provide precision treatment; improved surveillance, stewardship programs, and international collaboration play important roles in mitigating AMR
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review outlines a conceptual framework for addressing AMR through multiple modalities but provides no quantitative evidence to guide clinical decision-making. Clinicians should recognize this as a synthesis of emerging possibilities rather than an evidence base for practice change.
This is a narrative review consolidating existing knowledge and proposing emerging strategies against AMR without presenting new primary evidence, clinical trial data, or quantitative outcomes.
As stated by the source record.
This review outlines a conceptual framework for addressing AMR through multiple modalities but provides no quantitative evidence to guide clinical decision-making. Clinicians should recognize this as a synthesis of emerging possibilities rather than an evidence base for practice change.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Introduction: Antimicrobial resistance (AMR) is among the greatest threats to global health. Increasing antimicrobial resistance among multidrug-resistant pathogens poses significant risks to health and economies due to the widespread overuse and misuse of antimicrobials in human healthcare, animal husbandry, and agriculture. This review aims to discuss the current and emerging strategies against AMR to ensure the sustainability of antimicrobial therapies. Methods: This review consolidates findings from recent studies on the mechanisms of AMR, its impact on healthcare systems, and new therapeutic approaches. Combination therapies, vaccination strategies, advanced drug delivery systems, and unconventional methods involving Clustered Regularly Interspersed Short Palindromic Repeats (CRISPR)-Cas systems and artificial intelligence (AI)-driven diagnostics are discussed. Results and Discussion: AMR has acquired novel mechanisms, such as enzyme alteration and bio-film development, that render standard antibiotics less effective. Some promising strategies include novel drug delivery platforms, synergistic drug combinations, and gene-editing technologies such as CRISPR-Cas. AI-based diagnostics provide precision treatment, while improved surveillance, stewardship programs, and international collaboration play important roles in mitigating AMR. Although limited progress has been made in developing new antibiotics, these newer approaches promise to revolutionise the management of AMR. Conclusion: Overall, it is clear that AMR presents several urgent and equally complex global health challenges. Addressing these challenges requires breakthrough therapies in line with a multidisciplinary One Health perspective. Public education and awareness, sustained by investment in research, are considered essential to prolong the efficacy of antibiotics and safeguard public health.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.